Role of toll-like receptor 9 signaling in experimental leishmania braziliensis infection

Infection and Immunity

Volumn 81, Issue 5, 2013, Pages 1575-1584

  Weinkopff, Tiffany ^a   Mariotto, Anita ^a   Simon, Gregoire ^a   Torre, Yazmin Hauyon La ^a   Auderset, Floriane ^a   Schuster, Steffen ^a   Zangger, Haroun ^a   Fasel, Nicolas ^a   Barral, Aldina ^b   Tacchini Cottier, Fabienne ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b FEDERAL UNIVERSITY OF BAHIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12P40; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DISEASE PREDISPOSITION; DISEASE SEVERITY; FEMALE; HELPER CELL; IN VITRO STUDY; INFLAMMATION; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS; LYMPHOCYTE ACTIVATION; MOUSE; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UPREGULATION;

ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; MICE; MICE, INBRED C57BL; TH1 CELLS; TOLL-LIKE RECEPTOR 9;

EID: 84877827942     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01401-12     Document Type: Article

References (59)

1. Reithinger R, Dujardin JC, Louzir H, Pirmez C, Alexander B, Brooker S. 2007. Cutaneous leishmaniasis. Lancet Infect. Dis. 7:581-596.
2. Bittencourt AL, Barral A. 1991. Evaluation of the histopathological classifications of American cutaneous and mucocutaneous leishmaniasis. Mem. Inst. Oswaldo Cruz 86:51-56.
3. Marsden PD. 1985. Clinical presentations of Leishmania braziliensis braziliensis. Parasitol. Today 1:129-133.
4. Carvalho EM, Johnson WD, Barreto E, Marsden PD, Costa JL, Reed S, Rocha H. 1985. Cell mediated immunity in American cutaneous and mucosal leishmaniasis. J. Immunol. 135:4144-4148.
5. Marsden PD. 1986. Mucosal leishmaniasis ("espundia" Escomel, 1911). Trans. R. Soc. Trop. Med. Hyg. 80:859-876.
6. Bacellar O, Lessa H, Schriefer A, Machado P, Ribeiro de Jesus A, Dutra WO, Gollob KJ, Carvalho EM. 2002. Up-regulation of Th1-type responses in mucosal leishmaniasis patients. Infect. Immun. 70:6734-6740.
7. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceicao-Silva F, Modlin RL. 1993. Cytokine patterns in the pathogenesis of human leishmaniasis. J. Clin. Invest. 91:1390-1395.
8. Childs GE, Lightner LK, McKinney L, Groves MG, Price EE, Hendricks LD. 1984. Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica. Ann. Trop. Med. Parasitol. 78:25-34.
9. DeKrey GK, Lima HC, Titus RG. 1998. Analysis of the immune responses of mice to infection with Leishmania braziliensis. Infect. Immun. 66:827-829.
10. Indiani de Oliveira C, Teixeira MJ, Teixeira CR, Ramos de Jesus J, Bomura Rosato A, Santa da Silva J, Brodskyn C, Barral-Netto M, Barral A. 2004. Leishmania braziliensis isolates differing at the genome level display distinctive features in BALB/c mice. Microbes Infect. 6:977-984.
11. Maioli TU, Takane E, Arantes RM, Fietto JL, Afonso LC. 2004. Immune response induced by New World Leishmania species in C57BL/6 mice. Parasitology Res. 94:207-212.
12. Neal RA, Hale C. 1983. A comparative study of susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniases. Parasitology 87(Part 1):7-13.
13. Samuelson J, Lerner E, Tesh R, Titus R. 1991. A mouse model of Leishmania braziliensis braziliensis infection produced by coinjection with sand fly saliva. J. Exp. Med. 173:49-54.
14. de Souza-Neto SM, Carneiro CM, Vieira LQ, Afonso LC. 2004. Leishmania braziliensis: partial control of experimental infection by interleukin-12 p40 deficient mice. Mem. Inst. Oswaldo Cruz 99:289-294.
15. Rocha FJ, Schleicher U, Mattner J, Alber G, Bogdan C. 2007. Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice. Infect. Immun. 75:3823-3832.
16. Vargas-Inchaustegui DA, Xin L, Soong L. 2008. Leishmania braziliensis infection induces dendritic cell activation, ISG15 transcription, and the generation of protective immune responses. J. Immunol. 180:7537-7545.
17. Bennett CL, Misslitz A, Colledge L, Aebischer T, Blackburn CC. 2001. Silent infection of bone marrow-derived dendritic cells by Leishmania mexicana amastigotes. Eur. J. Immunol. 31:876-883.
18. Carvalho LP, Pearce EJ, Scott P. 2008. Functional dichotomy of dendritic cells following interaction with Leishmania braziliensis: infected cells produce high levels of TNF-alpha, whereas bystander dendritic cells are activated to promote T cell responses. J. Immunol. 181:6473-6480.
19. Soong L. 2008. Modulation of dendritic cell function by Leishmania parasites. J. Immunol. 180:4355-4360.
20. Müller I, Freudenberg M, Kropf P, Kiderlen AF, Galanos C. 1997. Leishmania major infection in C57BL/10 mice differing at the Lps locus: a new non-healing phenotype. Med. Microbiol. Immunol. 186:75-81.
21. Kropf P, Freudenberg MA, Modolell M, Price HP, Herath S, Antoniazi S, Galanos C, Smith DF, Muller I. 2004. Toll-like receptor 4 contributes to efficient control of infection with the protozoan parasite Leishmania major. Infect. Immun. 72:1920-1928.
22. Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C, Freudenberg M, Muller I. 2004. Infection of C57BL/10ScCr and C57BL/ 10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication. J. Leukoc. Biol. 76:48-57.
23. Schleicher U, Liese J, Knippertz I, Kurzmann C, Hesse A, Heit A, Fischer JA, Weiss S, Kalinke U, Kunz S, Bogdan C. 2007. NK cell activation in visceral leishmaniasis requires TLR9, myeloid DCs, and IL-12, but is independent of plasmacytoid DCs. J. Exp. Med. 204:893-906.
24. Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V. 2008. Toll-like receptors and leishmaniasis. Infect. Immun. 76:866-872.
25. Liese J, Schleicher U, Bogdan C. 2007. TLR9 signaling is essential for the innateNKcell response in murine cutaneous leishmaniasis. Eur. J. Immunol. 37:3424-3434.
26. de Veer MJ, Curtis JM, Baldwin TM, DiDonato JA, Sexton A, McConville MJ, Handman E, Schofield L. 2003. MyD88 is essential for clearance of Leishmania major: possible role for lipophosphoglycan and Tolllike receptor 2 signaling. Eur. J. Immunol. 33:2822-2831.
27. Debus A, Glasner J, Rollinghoff M, Gessner A. 2003. High levels of susceptibility and T helper 2 response in MyD88-deficient mice infected with Leishmania major are interleukin-4 dependent. Infect. Immun. 71: 7215-7218.
28. Muraille E, De Trez C, Brait M, De Baetselier P, Leo O, Carlier Y. 2003. Genetically resistant mice lacking MyD88-adapter protein display a high susceptibility to Leishmania major infection associated with a polarized Th2 response. J. Immunol. 170:4237-4241.
29. Revaz-Breton M, Ronet C, Ives A, Torre YH, Masina S, Tacchini-Cottier F, Launois P. 2010. The MyD88 protein 88 pathway is differently involved in immune responses induced by distinct substrains of Leishmania major. Eur. J. Immunol. 40:1697-1707.
30. Abou Fakher FH, Rachinel N, Klimczak M, Louis J, Doyen N. 2009. TLR9-dependent activation of dendritic cells by DNA from Leishmania major favors Th1 cell development and the resolution of lesions. J. Immunol. 182:1386-1396.
31. Carvalho LP, Petritus PM, Trochtenberg AL, Zaph C, Hill DA, Artis D, Scott P. 2012. Lymph node hypertrophy following Leishmania major infection is dependent on TLR9. J. Immunol. 188:1394-1401.
32. Tacchini-Cottier F, Weinkopff T, Launois P. 2012. Does T helper differentiation correlate with resistance or susceptibility to infection with L. major? Some insights from the murine model. Front. Immunol. 3:32.
33. Vargas-Inchaustegui DA, Tai W, Xin L, Hogg AE, Corry DB, Soong L. 2009. Distinct roles for MyD88 and Toll-like receptor 2 during Leishmania braziliensis infection in mice. Infect. Immun. 77:2948-2956.
34. de Moura TR, Novais FO, Oliveira F, Clarencio J, Noronha A, Barral A, Brodskyn C, de Oliveira CI. 2005. Toward a novel experimental model of infection to study American cutaneous leishmaniasis caused by Leishmania braziliensis. Infect. Immun. 73:5827-5834.
35. Titus RG, Marchand M, Boon T, Louis JA. 1985. A limiting dilution assay for quantifying Leishmania major in tissues of infected mice. Parasite Immunol. 7:545-555.
36. Taswell C. 1981. Limiting dilution assays for the determination of immunocompetent cell frequencies. I. Data analysis. J. Immunol. 126:1614-1619.
37. Ives A, Ronet C, Prevel F, Ruzzante G, Fuertes-Marraco S, Schutz F, Zangger H, Revaz-Breton M, Lye LF, Hickerson SM, Beverley SM, Acha-Orbea H, Launois P, Fasel N, Masina S. 2011. Leishmania RNA virus controls the severity of mucocutaneous leishmaniasis. Science 331: 775-778.
38. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM. 1992. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/ macrophage colony-stimulating factor. J. Exp. Med. 176:1693-1702.
39. Brasel K, De Smedt T, Smith JL, Maliszewski CR. 2000. Generation of murine dendritic cells from flt3-ligand-supplemented bone marrow cultures. Blood 96:3029-3039.
40. Charmoy M, Megnekou R, Allenbach C, Zweifel C, Perez C, Monnat K, Breton M, Ronet C, Launois P, Tacchini-Cottier F. 2007. Leishmania major induces distinct neutrophil phenotypes in mice that are resistant or susceptible to infection. J. Leukoc. Biol. 82:288-299.
41. Otten LA, Tacchini-Cottier F, Lohoff M, Annunziato F, Cosmi L, Scarpellino L, Louis J, Steimle V, Reith W, Acha-Orbea H. 2003. Deregulated MHC class II transactivator expression leads to a strong Th2 bias in CD4β T lymphocytes. J. Immunol. 170:1150-1157.
42. Ronet C, Hauyon-La Torre Y, Revaz-Breton M, Mastelic B, Tacchini-Cottier F, Louis J, Launois P. 2010. Regulatory B cells shape the development of Th2 immune responses in BALB/c mice infected with Leishmania major through IL-10 production. J. Immunol. 184:886-894.
43. Charmoy M, Brunner-Agten S, Aebischer D, Auderset F, Launois P, Milon G, Proudfoot AE, Tacchini-Cottier F. 2010. Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice. PLoS Pathog. 6:e1000755. doi:10.1371/journal.ppat.1000755.
44. Chakour R, Allenbach C, Desgranges F, Charmoy M, Mauel J, Garcia I, Launois P, Louis J, Tacchini-Cottier F. 2009. A new function of the Fas-FasL pathway in macrophage activation. J. Leukoc. Biol. 86:81-90.
45. Salinas G, Zamora M, Stuart K, Saravia N. 1996. Leishmania RNA viruses in Leishmania of the Viannia subgenus. Am. J. Trop. Med. Hyg. 54:425-429.
46. Barral A, Barral-Netto M, Almeida R, de Jesus AR, Grimaldi Junior G, Netto EM, Santos I, Bacellar O, Carvalho EM. 1992. Lymphadenopathy associated with Leishmania braziliensis cutaneous infection. Am. J. Trop. Med. Hyg. 47:587-592.
47. Barral A, Guerreiro J, Bomfim G, Correia D, Barral-Netto M, Carvalho EM. 1995. Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis. Am. J. Trop. Med. Hyg. 53:256-259.
48. Leite PM, Gomes RS, Figueiredo AB, Serafim TD, Tafuri WL, de Souza CC, Moura SA, Fietto JL, Melo MN, Ribeiro-Dias F, Oliveira MA, Rabello A, Afonso LC. 2012. Ecto-nucleotidase activities of promastigotes from Leishmania (Viannia) braziliensis relates to parasite infectivity and disease clinical outcome. PLoS Negl. Trop. Dis. 6:e1850. doi:10.1371 /journal.pntd.0001850.
49. Teixeira MJ, Fernandes JD, Teixeira CR, Andrade BB, Pompeu ML, Santana da Silva J, Brodskyn CI, Barral-Netto M, Barral A. 2005. Distinct Leishmania braziliensis isolates induce different paces of chemokine expression patterns. Infect. Immun. 73:1191-1195.
50. Xin L, Li K, Soong L. 2008. Down-regulation of dendritic cell signaling pathways by Leishmania amazonensis amastigotes. Mol. Immunol. 45: 3371-3382.
51. Gomes IN, Calabrich AF, Tavares Rda S, Wietzerbin J, de Freitas LA, Veras PS. 2003. Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania. Microbes Infect. 5:251-260.
52. Giudice A, Camada I, Leopoldo PT, Pereira JM, Riley LW, Wilson ME, Ho JL, de Jesus AR, Carvalho EM, Almeida RP. 2007. Resistance of Leishmania (Leishmania) amazonensis and Leishmania (Viannia) braziliensis to nitric oxide correlates with disease severity in tegumentary leishmaniasis. BMC Infect. Dis. 7:7.
53. Mukbel RM, Patten C, Jr, Gibson K, Ghosh M, Petersen C, Jones DE. 2007. Macrophage killing of Leishmania amazonensis amastigotes requires both nitric oxide and superoxide. Am. J. Trop. Med. Hyg. 76:669-675.
54. Souza AS, Giudice A, Pereira JM, Guimaraes LH, de Jesus AR, de Moura TR, Wilson ME, Carvalho EM, Almeida RP. 2010. Resistance of Leishmania (Viannia) braziliensis to nitric oxide: correlation with antimony therapy and TNF-alpha production. BMC Infect. Dis. 10:209.
55. Skokos D, Nussenzweig MC. 2007. CD8 DCs induce IL-12-independent Th1 differentiation through Delta 4 Notch-like ligand in response to bacterial LPS. J. Exp. Med. 204:1525-1531.
56. Soares H, Waechter H, Glaichenhaus N, Mougneau E, Yagita H, Mizenina O, Dudziak D, Nussenzweig MC, Steinman RM. 2007. A subset of dendritic cells induces CD4βT cells to produce IFN-gamma by an IL-12-independent but CD70-dependent mechanism in vivo. J. Exp. Med. 204: 1095-1106.
57. Müller U, Kohler G, Mossmann H, Schaub GA, Alber G, Di Santo JP, Brombacher F, Holscher C. 2001. IL-12-independent IFN-gamma production by T cells in experimental Chagas' disease is mediated by IL-18. J. Immunol. 167:3346-3353.
58. Sousa Ade Q, Parise ME, Pompeu MM, Coehlo Filho JM, Vasconcelos IA, Lima JW, Oliveira EG, Vasconcelos AW, David JR, Maguire JH. 1995. Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil. Am. J. Trop. Med. Hyg. 53: 380-385.
59. Guillerey C, Mouries J, Polo G, Doyen N, Law HK, Chan S, Kastner P, Leclerc C, Dadaglio G. 2012. Pivotal role of plasmacytoid dendritic cells in inflammation and NK-cell responses after TLR9 triggering in mice. Blood 120:90-99.